Riskpilot← Back to searchSign inGet full accessSYNSENTERET AS
ASActiveOrg 951538744Bakkegata 3, 2815 GjøvikRetail sale of medical and orthopaedic goods · NACE 4774Est. 19893 employees
Revenue 2024
NOK 6,9M
+18% vs 2023
EBITDA margin
15.8%
-4% vs 2023
Equity ratio
31.5%
Financial strength
Net profit 2024
NOK 799K
-7% vs 2023
| Revenue | NOK 6,9M | +18% |
| EBITDA | NOK 1,1M | -4% |
| Net profit | NOK 799K | -7% |
| Total assets | NOK 2,5M | +3% |
| Equity | NOK 775K | +15% |
| Employees | 3 | — |
Legal name
SYNSENTERET AS
Org number
951538744
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
2. januar 1989
Share capital
NOK 100 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Address
Bakkegata 3, 2815 Gjøvik
Phone
+4761172334
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 565 | 3 110 | 6 095 | 5 830 | 6 887 |
| Staff expenses | −1 626 | −1 098 | −2 131 | −2 019 | −2 822 |
| EBITDA | 938 | 139 | 959 | 1 130 | 1 090 |
| Depreciation & amort. | −13 | −12 | −32 | −46 | −70 |
| EBIT | 925 | 127 | 927 | 1 084 | 1 019 |
| Net financials | 8 | 2 | −20 | 13 | 2 |
| Profit before tax | 934 | 129 | 907 | 1 096 | 1 021 |
| Tax | 133 | 28 | 206 | 241 | 222 |
| Net profit | 800 | 100 | 702 | 855 | 799 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 130 | 1 043 | 2 355 | 2 388 | 2 457 |
| Equity | 654 | 174 | 376 | 676 | 775 |
| Long-term debt | 16 | 9 | 9 | 8 | 3 |
| Short-term debt | 2 460 | 859 | 1 970 | 1 705 | 1 680 |
| Total debt | 2 476 | 869 | 1 979 | 1 713 | 1 682 |
EBITDA margin
15.8%
This company
15.8%
Market median
+0% vs market
20202024
Equity ratio
31.5%
This company
38.2%
Market median
+18% vs market
20202024
Return on equity
103.1%
This company
18.4%
Market median
+460% vs market
20202024
Net profit margin
11.6%
This company
8.1%
Market median
+43% vs market
20202024
Asset turnover
2.80×
This company
1.12×
Market median
+150% vs market
20202024
Debt / equity
2.17×
This company
0.62×
Market median
-250% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MK Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
HB Deputy Member | Deputy Member | 1993 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Former (1) | ||
| Chairman | 1993 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 47% | 47% | 2024 | |
| Company | 47% | 47% | 2024 | |
| Individual | 3% | 3% | 2024 | |
| Individual | 3% | 3% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Jj-Holding As
SYNSENTERET AS Board members of SYNSENTERET AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Bondlid | Deputy Member | 0 companies |
| Magnus Karl Ingemar Andersson | Chief Executive Officer | 0 companies |
| Inger Johanne Løkkevik | Board of Directors | 0 companies |
| Jacob Lindbom Jacobsen | Chairman | 0 companies |
| Knut Sønes | Chairman | 0 companies |